4/A//SEC Filing
GANZI VICTOR F 4/A
Accession 0001601485-22-000044
CIK 0001601485other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:19 PM ET
Size
8.3 KB
Accession
0001601485-22-000044
Insider Transaction Report
Form 4/AAmended
GANZI VICTOR F
Director
Transactions
- Sale
Common Stock
2021-02-09$16.00/sh−246,720$3,947,520→ 823,117 total - Exercise of In-Money
Warrant to Purchase Common Stock
2021-02-09−614,310→ 0 totalExercise: $6.43Exp: 2028-07-05→ Common Stock (614,310 underlying) - Exercise of In-Money
Common Stock
2021-02-09$6.43/sh+614,310$3,950,013→ 1,069,837 total
Footnotes (1)
- [F1]On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person.
Documents
Issuer
Angion Biomedica Corp.
CIK 0001601485
Entity typeother
Related Parties
1- filerCIK 0001199070
Filing Metadata
- Form type
- 4/A
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 4:19 PM ET
- Size
- 8.3 KB